
Dayclazide Total 30mg/15mg/500mg Tablet SR
Marketer
Daylon Healthcare
Salt Composition
Gliclazide (30mg) + Pioglitazone (15mg) + Metformin (500mg)
Overview Dayclazide Total 30mg/15mg/500mg Tablet SR
Tri-Comb 30mg/15mg/500mg Extended-Release Tablets are prescribed for managing type 2 diabetes. This medication assists adults in regulating blood glucose. Administer Tri-Comb 30mg/15mg/500mg ER Tablets with food, ideally at the same time daily. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms (sweating, lightheadedness, headache) and implement appropriate countermeasures like consuming readily available glucose sources (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include nausea, altered taste, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart conditions should inform their doctor before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function) are typically recommended.
Primary Ingredients of Dayclazide Total 30mg/15mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Dayclazide Total 30mg/15mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Dayclazide Total 30mg/15mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Dayclazide Total 30mg/15mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with food.
Common Side effects of Dayclazide Total 30mg/15mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Bronchitis (inflammation of the airways)
- Anemia (low number of red blood cells)
- Edema (swelling)
How to use Dayclazide Total 30mg/15mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dayclazide Total 30mg/15mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.
How Dayclazide Total 30mg/15mg/500mg Tablet SR works:
Dayclazide SR tablets (30mg/15mg/500mg) combine gliclazide, pioglitazone, and metformin—three distinct antidiabetic agents. This triple-action approach improves blood glucose management when monotherapy or dual therapy proves insufficient. Gliclazide (a sulfonylurea) stimulates pancreatic insulin release, reducing blood sugar levels. Pioglitazone (a thiazolidinedione) enhances insulin sensitivity. Metformin (a biguanide) acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Dayclazide Total 30mg/15mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dayclazide 30mg/15mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Dayclazide 30mg/15mg/500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The extended-release Dayclazide 30mg/15mg/500mg tablet is likely unsuitable for individuals with impaired kidney function and its use should be avoided. Medical advice is recommended.
LiverUNSAFE
The combined medication Dayclazide Total (30mg/15mg/500mg sustained-release tablet) may pose significant risks for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.
What if you forget to take Dayclazide Total 30mg/15mg/500mg Tablet SR :
Should you forget a Dayclazide Total 30mg/15mg/500mg SR Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dayclazide Total 30mg/15mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
